PDMR Participation in SAYE Scheme

RNS Number : 9229T

Omega Diagnostics Group PLC

18 October 2017

 

Omega Diagnostics Group PLC

("Omega" or the "Company")

PDMR participation in SAYE scheme

Omega (AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, announces that certain PDMRs of the Company have been granted sharesave option awards in the Company's save as you earn scheme ("SAYE Scheme") which gives them the opportunity to participate in the future growth of the Company via share award arrangements.

The SAYE Scheme grants participants the option to purchase ordinary shares of 4 pence each in the capital of the Company ("Ordinary Share") at a price of 18.4 pence per Ordinary Share and is exercisable between 1 November 2020 and 1 May 2021.

Accordingly, the Company makes the following announcement and notification in accordance with the EU Market Abuse Regulation (No 596/2014):

1)	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	John Bannister
2.	Reason for notification
b)	Position / status	PDMR
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument  Identification code	Options over ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Grant of share options under the Company's SAYE Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.184 23,478
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	18 October 2017
f)	Place of the transaction	Outside a trading venue

1)	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Derek Brady
2.	Reason for notification
b)	Position / status	PDMR
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument  Identification code	Options over ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Grant of share options under the Company's SAYE Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.184 14,673
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	18 October 2017
f)	Place of the transaction	Outside a trading venue

1)	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Patrick Breen
2.	Reason for notification
b)	Position / status	PDMR
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument  Identification code	Options over ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Grant of share options under the Company's SAYE Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.184 19,565
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	18 October 2017
f)	Place of the transaction	Outside a trading venue

1)	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Michael Gordon
2.	Reason for notification
b)	Position / status	PDMR
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument  Identification code	Options over ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Grant of share options under the Company's SAYE Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.184 39,130
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	18 October 2017
f)	Place of the transaction	Outside a trading venue

1)	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Iain Logan
2.	Reason for notification
b)	Position / status	PDMR
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument  Identification code	Options over ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Grant of share options under the Company's SAYE Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.184 9,782
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	18 October 2017
f)	Place of the transaction	Outside a trading venue

1)	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Angela Robertson
2.	Reason for notification
b)	Position / status	PDMR
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument  Identification code	Options over ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Grant of share options under the Company's SAYE Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.184 19,565
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	18 October 2017
f)	Place of the transaction	Outside a trading venue

1)	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Edward Valente
2.	Reason for notification
b)	Position / status	PDMR
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument  Identification code	Options over ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Grant of share options under the Company's SAYE Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.184 78,260
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	18 October 2017
f)	Place of the transaction	Outside a trading venue

1)	Details of Persons Discharging Managerial Responsibilities "PDMR" / person closely associated with them ('PCA')
a)	Name	Jamie Yexley
2.	Reason for notification
b)	Position / status	PDMR
c)	Initial notification / amendment	Initial Notification
3.	Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
b)	Name	Omega Diagnostics Group plc
c)	LEI	2138007U9P4BTZTYIR92
4.	Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)	Description of the financial instrument  Identification code	Options over ordinary shares of 4p each GB00B1VCP282
b)	Nature of the transaction	Grant of share options under the Company's SAYE Scheme
c)	Price(s) and volume(s)	Price(s) Volume(s) £0.184 5,869
d)	Aggregated information Aggregated volume Price	n/a
e)	Date of the transaction	18 October 2017
f)	Place of the transaction	Outside a trading venue

Contacts:

Omega Diagnostics Group PLC	Tel: [phone]
Andrew Shepherd, Chief Executive	www.omegadiagnostics.com
Kieron Harbinson, Group Finance Director
Jag Grewal, Group Sales and Marketing Director
finnCap Ltd	Tel: [phone]
Geoff Nash/James Thompson (Corporate Finance)
Mia Gardner (Corporate Broking)
Walbrook PR Limited	Tel: [phone] or [e-mail]
Paul McManus	Mob: [phone]
Lianne Cawthorne	Mob: [phone]

 

END

 

 

DSHFFDSWAFWSEES